About
Dr. David Goode is a Senior Lecturer and head of the Cancer Bioinformatics and Tumour Evolution group at Monash University's Department of Biochemistry & Molecular Biology, affiliated with the Monash Biomedicine Discovery Institute. His research focuses on applying bioinformatics, molecular evolution, and population genetics to understand tumor evolution and therapy resistance in solid tumors like prostate and brain cancers. He has published 59 peer-reviewed articles (H-index 24) and led pioneering projects in cancer genomics and computational modeling.
Key projects include 'GLIMMER' (glioma liquid biopsy monitoring), radiotherapy advancements using microbeams, and bipolar androgen therapy for prostate cancer. His work contributes to UN Sustainable Development Goals related to health and innovation. Dr. Goode holds significant fellowships, including a Victorian Cancer Agency Mid-Career Fellowship (2018-2023) and NHMRC Early Career Fellowship (2013-2016).
- Research interests: Cancer bioinformatics, spatial transcriptomics, tumor evolution, gene regulatory networks
- Collaborations: Global network spanning oncology, genomics, and computational biology
